Ligand validation:4NM8

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4NM8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4NM8_NAG_B_201	17%	51%	0.246	0.824	0.54	1.32	-	2	1	0	100%	0.9333
4NM8_NAG_E_501	11%	59%	0.304	0.829	0.46	1.08	-	1	0	0	100%	0.9333
4NM8_NAG_C_501	9%	64%	0.313	0.805	0.5	0.88	-	1	0	0	100%	0.9333
4NM8_NAG_F_201	8%	47%	0.317	0.797	0.54	1.49	-	3	1	0	100%	0.9333
4NM8_NAG_E_502	4%	54%	0.338	0.731	0.5	1.27	-	1	0	0	100%	0.9333
4NM8_NAG_C_504	2%	60%	0.367	0.677	0.56	0.96	-	1	1	0	100%	0.9333
4NM8_NAG_D_201	2%	41%	0.403	0.705	0.55	1.71	-	3	2	0	100%	0.9333
4NM8_NAG_E_503	1%	60%	0.42	0.624	0.48	1.02	-	1	0	0	100%	0.9333
3HMG_NAG_A_334	81%	39%	0.002	0.851	0.94	1.45	-	3	0	0	100%	0.9333
4HMG_NAG_E_334	81%	47%	0.074	0.924	0.7	1.34	-	1	0	0	100%	0.9333
1HGI_NAG_C_329	78%	58%	0.084	0.925	0.7	0.9	-	1	0	0	100%	0.9333
5K9Q_NAG_F_201	76%	87%	0.08	0.916	0.2	0.49	-	-	0	0	100%	0.9333
2HMG_NAG_C_348	76%	52%	0.088	0.924	0.62	1.22	-	2	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.